Outcomes | Instruments |
---|---|
Patient-related primary data | |
Primary outcomes | |
Health-related quality of life | Short-form health survey (SF-36), mental component summary score [39] |
Secondary outcomes | |
Health-related quality of life | Short-form health survey (SF-36), physical component summary score [39], EuroQol-5D (EQ-5D) [40] |
Depressive symptoms | Patient Health Questionnaire – Depression Module (PHQ-9) [41] |
Anxiety symptoms | Patient Health Questionnaire – Generalized Anxiety Disorder Module (GAD-7) [42] |
Somatoform symptoms | Somatic Symptom Scale – 8 (SSS-8) [43] |
Alcohol consumption | Alcohol Use Disorders Identification Test (AUDIT) [44] |
Schizophrenic symptoms | Eppendorfer Schizophrenia Inventory – Short Version (ESI-K) [45] |
Adjustment disorder-symptoms | |
Physical and psychological impact of multiple sclerosis | |
Patient satisfaction with outpatient care | Satisfaction with ambulatory care (ZAPA) [50] |
Patient-related secondary data | |
Primary outcomes | |
Direct costs caused by outpatient and inpatient service utilization and medication within one year following diagnosis | Claims data about outpatient and inpatient service utilization and medication |
Secondary outcomes | |
Indirect costs caused by productivity losses | Days of incapacity to work and sick pay |
Level of detail of depression diagnoses | Claims data about diagnoses (specific: F32.0-F32.3, F33.0-F33.4; unspecific: F32.8, F32.9, F33.8, F33.9) |
Health care provider-related primary data | |
Aspects of the PNP program - access - reasons for participation - barriers to participation - advantages and disadvantages of participation - differences in health care - appropriateness of compensation - organizational aspects - interprofessional cooperation - evaluation and use of contract components | Questionnaire on structure and process quality of the PNP program, in-house development based on - qualitative interviews with selected health care providers - a questionnaire from another project (see [51]) |